About DanausGT Biotechnology Limited
DanausGT Biotechnology LimitedDanausGT Biotech is a global company focused on the usage of gene editing technology and cell therapy to treat a wide range of diseases. The company has independent intellectual property rights of CRISPR/AAV technology platform, which can achieve precise gene replacement to completely cure patients, editing efficiency of up to 80%, and is constantly improving. At present, several projects are simultaneously in the stages from preclinical to clinical Phase I.
